| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shweta Patel, Sahar Khan, Saipavankumar M, Pousettef Hami. The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review. Cureus. vol 12. issue 7. 2020-09-28. PMID:32839678. |
from the current data, we can conclude that the tetrahydrocannabinol (thc) component of cannabis can be the main culprit causing psychosis and schizophrenia in the at-risk population. |
2020-09-28 |
2023-08-13 |
human |
| Shweta Patel, Sahar Khan, Saipavankumar M, Pousettef Hami. The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review. Cureus. vol 12. issue 7. 2020-09-28. PMID:32839678. |
the relation between cannabis and schizophrenia needs further investigation. |
2020-09-28 |
2023-08-13 |
human |
| Brian S Barnett, Veronica Kusunzi, Lucy Magola, Christina P C Borba, Michael Udedi, Kazione Kulisewa, Mina C Hosseinipou. Description of the inpatient population and care received at a psychiatric unit in Lilongwe, Malawi. International journal of culture and mental health. vol 11. issue 4. 2020-09-28. PMID:32863863. |
schizophrenia (30.1%), cannabis use disorder (27.9%) and alcohol use disorder (25.1%) were the most common diagnoses. |
2020-09-28 |
2023-08-13 |
Not clear |
| Ashleigh L Osborne, Nadia Solowij, Ilijana Babic, Jeremy S Lum, Kelly A Newell, Xu-Feng Huang, Katrina Weston-Gree. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 95. 2020-08-26. PMID:31202911. |
effect of cannabidiol on endocannabinoid, glutamatergic and gabaergic signalling markers in male offspring of a maternal immune activation (poly i:c) model relevant to schizophrenia. |
2020-08-26 |
2023-08-13 |
rat |
| b' Branka Aukst Margetic, Vjekoslav Peitl, Ines Vukasovi\\xc4\\x87, Dalibor Karlovi\\xc4\\x8. Neuregulin-1 is increased in schizophrenia patients with chronic cannabis abuse: Preliminary results. Schizophrenia research. vol 208. 2020-07-30. PMID:30799217.' |
neuregulin-1 is increased in schizophrenia patients with chronic cannabis abuse: preliminary results. |
2020-07-30 |
2023-08-13 |
Not clear |
| Marina Mitjans, Jan Seidel, Martin Begemann, Fabian Bockhop, Jorge Moya-Higueras, Vikas Bansal, Janina Wesolowski, Anna Seelbach, Manuel Ignacio Ibáñez, Fatka Kovacevic, Oguzhan Duvar, Lourdes Fañanás, Hannah-Ulrike Wolf, Generós Ortet, Peter Zwanzger, Verena Klein, Ina Lange, Andreas Tänzer, Manuela Dudeck, Lars Penke, Ludger Tebartz van Elst, Robert A Bittner, Richard Schmidmeier, Roland Freese, Rüdiger Müller-Isberner, Jens Wiltfang, Thomas Bliesener, Stefan Bonn, Luise Poustka, Jürgen L Müller, Bárbara Arias, Hannelore Ehrenreic. Violent aggression predicted by multiple pre-adult environmental hits. Molecular psychiatry. vol 24. issue 10. 2020-05-21. PMID:29795411. |
we determined in 6 independent cohorts (4 schizophrenia and 2 general population samples) pre-adult risk exposure, comprising urbanicity, migration, physical and sexual abuse as primary, and cannabis or alcohol as secondary hits. |
2020-05-21 |
2023-08-13 |
human |
| Stephanie M Perez, Jennifer J Donegan, Angela M Boley, David D Aguilar, Andrea Giuffrida, Daniel J Lodg. Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat. Schizophrenia research. vol 206. 2020-05-19. PMID:30522798. |
adolescent cannabis use has been implicated as a risk factor for schizophrenia; however, it is neither necessary nor sufficient. |
2020-05-19 |
2023-08-13 |
human |
| Arsalan Arsalan, Zafar Iqbal, Muhammad Tariq, Oyedeji Ayonrinde, John B Vincent, Muhammad Ayu. Association of smoked cannabis with treatment resistance in schizophrenia. Psychiatry research. vol 278. 2020-03-31. PMID:31229838. |
association of smoked cannabis with treatment resistance in schizophrenia. |
2020-03-31 |
2023-08-13 |
human |
| Arsalan Arsalan, Zafar Iqbal, Muhammad Tariq, Oyedeji Ayonrinde, John B Vincent, Muhammad Ayu. Association of smoked cannabis with treatment resistance in schizophrenia. Psychiatry research. vol 278. 2020-03-31. PMID:31229838. |
association of cannabis use with schizophrenia is a well-established finding. |
2020-03-31 |
2023-08-13 |
human |
| Arsalan Arsalan, Zafar Iqbal, Muhammad Tariq, Oyedeji Ayonrinde, John B Vincent, Muhammad Ayu. Association of smoked cannabis with treatment resistance in schizophrenia. Psychiatry research. vol 278. 2020-03-31. PMID:31229838. |
different studies have found that cannabis use impacts the outcome of schizophrenia and is associated with treatment non-adherence and a higher rate of relapses. |
2020-03-31 |
2023-08-13 |
human |
| Arsalan Arsalan, Zafar Iqbal, Muhammad Tariq, Oyedeji Ayonrinde, John B Vincent, Muhammad Ayu. Association of smoked cannabis with treatment resistance in schizophrenia. Psychiatry research. vol 278. 2020-03-31. PMID:31229838. |
in this paper, we investigated the impact of self-reported cannabis use on treatment response in a cohort of schizophrenia patients from pakistan, a middle-income country. |
2020-03-31 |
2023-08-13 |
human |
| Carlos Jimenez Naranjo, Ashleigh L Osborne, Katrina Weston-Gree. Effect of cannabidiol on muscarinic neurotransmission in the pre-frontal cortex and hippocampus of the poly I:C rat model of schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 94. 2020-03-30. PMID:31108177. |
effect of cannabidiol on muscarinic neurotransmission in the pre-frontal cortex and hippocampus of the poly i:c rat model of schizophrenia. |
2020-03-30 |
2023-08-13 |
rat |
| Maykel Farag Ghabrash, Stephanie Coronado-Montoya, John Aoun, Andrée-Anne Gagné, Flavi Mansour, Clairélaine Ouellet-Plamondon, Annie Trépanier, Didier Jutras-Aswa. Cannabidiol for the treatment of psychosis among patients with schizophrenia and other primary psychotic disorders: A systematic review with a risk of bias assessment. Psychiatry research. vol 286. 2020-03-24. PMID:32126328. |
cannabidiol for the treatment of psychosis among patients with schizophrenia and other primary psychotic disorders: a systematic review with a risk of bias assessment. |
2020-03-24 |
2023-08-13 |
human |
| Nathan T Pearson, James H Berr. Cannabis and Psychosis Through the Lens of DSM-5. International journal of environmental research and public health. vol 16. issue 21. 2020-03-16. PMID:31661851. |
in the present review we examine cannabis/psychosis associations as they pertain to cannabis intoxication, cannabis-induced psychotic disorder, and schizophrenia. |
2020-03-16 |
2023-08-13 |
Not clear |
| Nathan T Pearson, James H Berr. Cannabis and Psychosis Through the Lens of DSM-5. International journal of environmental research and public health. vol 16. issue 21. 2020-03-16. PMID:31661851. |
cannabis intoxication becomes cannabis-induced psychotic disorder once certain severity and duration criteria are met and cannabis-induced psychotic disorder is heavily associated with future schizophrenia diagnoses. |
2020-03-16 |
2023-08-13 |
Not clear |
| Ryan L Goetz, Brian J Mille. Total and Differential White Blood Cell Counts, Cocaine, and Marijuana Use in Patients With Schizophrenia. The Journal of nervous and mental disease. vol 207. issue 8. 2020-03-11. PMID:31232907. |
we examined effects of marijuana and cocaine use on white blood cell (wbc) counts in acutely ill, hospitalized patients with schizophrenia using a within-subjects and between-groups design. |
2020-03-11 |
2023-08-13 |
Not clear |
| Ryan L Goetz, Brian J Mille. Total and Differential White Blood Cell Counts, Cocaine, and Marijuana Use in Patients With Schizophrenia. The Journal of nervous and mental disease. vol 207. issue 8. 2020-03-11. PMID:31232907. |
mean total and differential wbc counts were first compared in acutely ill patients with schizophrenia for hospitalizations with and without either marijuana (n = 18) or cocaine (n = 24) use. |
2020-03-11 |
2023-08-13 |
Not clear |
| Ryan L Goetz, Brian J Mille. Total and Differential White Blood Cell Counts, Cocaine, and Marijuana Use in Patients With Schizophrenia. The Journal of nervous and mental disease. vol 207. issue 8. 2020-03-11. PMID:31232907. |
mean total and differential wbc counts were then compared between patients with schizophrenia with either marijuana or cocaine use and patients with a negative urine drug screen (uds; n = 43). |
2020-03-11 |
2023-08-13 |
Not clear |
| Ian Hamilton, Mark Monagha. Cannabis and Psychosis: Are We any Closer to Understanding the Relationship? Current psychiatry reports. vol 21. issue 7. 2020-03-09. PMID:31161275. |
this paper provides an update from the literature on understanding of the relationship between cannabis and schizophrenia. |
2020-03-09 |
2023-08-13 |
Not clear |
| Cecilia María Díaz-Soto, Guillermo Alonso Castaño-Pérez, David Antonio Pineda-Salaza. Cannabis, schizophrenia and cognition: the contribution of brain connectivity. Adicciones. vol 0. issue 0. 2020-02-26. PMID:32100035. |
cannabis, schizophrenia and cognition: the contribution of brain connectivity. |
2020-02-26 |
2023-08-13 |
Not clear |